Breaking News

Syntagon Appoints New CEO

Makes changes to management team

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. Andis Slaitas will replace Dr. Michael Lofthagen as Syntagon’s chief executive officer. Dr. Slaitas has been with the company since 2005 and has been instrumental in developing the Syntagon Baltic chemistry facility, based in Latvia. Previously he was vice president of operations at Syntagon with responsibility for production, management and operations at the Latvian and Swedish operations.   The ownership of Syntagon will remain with its founders, Michael Lofthagen and Paul Alhadeff, and th...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters